Skip to main content


Table 2 Oncotype DX validation on GSE17705

From: The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures

  HR p value CI upper CI lower
Combined Patients 1.74 5.5E-02 0.99 3.07
LN- Patients 3.58 1.2E-02 1.38 9.27
LN+ Patients 1.16 6.8E-01 0.57 2.34